Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.
Valuation and Earnings
This table compares Alignment Healthcare and Precipio”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $3.95 billion | 0.38 | -$720,000.00 | $0.13 | 54.88 |
| Precipio | $24.05 million | 1.37 | -$360,000.00 | ($0.64) | -28.77 |
Precipio has lower revenue, but higher earnings than Alignment Healthcare. Precipio is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Alignment Healthcare and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.59% | 12.46% | 2.36% |
| Precipio | -4.47% | -8.49% | -5.75% |
Risk & Volatility
Alignment Healthcare has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500.
Insider & Institutional Ownership
86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 10.4% of Precipio shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by insiders. Comparatively, 16.6% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Alignment Healthcare and Precipio, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 1 | 6 | 6 | 0 | 2.38 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
Alignment Healthcare currently has a consensus target price of $14.18, suggesting a potential upside of 98.76%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, equities analysts clearly believe Alignment Healthcare is more favorable than Precipio.
Summary
Alignment Healthcare beats Precipio on 10 of the 14 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
